SBRT Plus Nivolumab in Advanced NSCLC: A Phase II Multicenter Study With Exploratory Bone Metastases Subgroup Analysis.
- DOI
- 10.1016/j.cllc.2026.08.012
- Published
- 2026 Aug 25
- Container
- Clinical lung cancer
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cllc.2026.08.012,
title = {SBRT Plus Nivolumab in Advanced NSCLC: A Phase II Multicenter Study With Exploratory Bone Metastases Subgroup Analysis.},
author = {Luo Y and Wang Y and Ren P and Li Y and Gao S and Ye H and Zhang Y and Gui Y and Liu Y and Zhang Y and Jun P and Du L and Li J and Wei C and Wang Y and Zhu B and Pang H and Lin S},
year = {2026},
journal = {Clinical lung cancer},
doi = {10.1016/j.cllc.2026.08.012},
url = {https://doi.org/10.1016/j.cllc.2026.08.012}
}RIS
TY - JOUR TI - SBRT Plus Nivolumab in Advanced NSCLC: A Phase II Multicenter Study With Exploratory Bone Metastases Subgroup Analysis. AU - Luo Y AU - Wang Y AU - Ren P AU - Li Y AU - Gao S AU - Ye H AU - Zhang Y AU - Gui Y AU - Liu Y AU - Zhang Y AU - Jun P AU - Du L AU - Li J AU - Wei C AU - Wang Y AU - Zhu B AU - Pang H AU - Lin S PY - 2026 JO - Clinical lung cancer DO - 10.1016/j.cllc.2026.08.012 UR - https://doi.org/10.1016/j.cllc.2026.08.012 ER -
APA
Y, L., Y, W., P, R., Y, L., S, G., H, Y., Y, Z., Y, G., Y, L., Y, Z., P, J., L, D., J, L., C, W., Y, W., B, Z., H, P., & S, L. (2026). SBRT Plus Nivolumab in Advanced NSCLC: A Phase II Multicenter Study With Exploratory Bone Metastases Subgroup Analysis.. Clinical lung cancer. https://doi.org/10.1016/j.cllc.2026.08.012
Source records
- pubmed · retrieved 2026-09-26T09:37:10.290Z